GridAI Technologies (GRDX) Convertible Debt (2015 - 2020)
GridAI Technologies' (GRDX) quarterly Convertible Debt came in at $5.3 million in Q2 2020, up 187.69% on a YoY basis from $1.8 million in Q3 2019, and up 76.98% quarter-over-quarter from $3.0 million in Q1 2020.
Analysis
GridAI Technologies (GRDX) Convertible Debt (2015 - 2020) Analysis & Trends
GridAI Technologies (GRDX) has reported Convertible Debt for 6 consecutive years, with $5.3 million the latest figure, recorded in Q2 2020.
- For the quarter ending Q2 2020, Convertible Debt rose 187.69% year-over-year to $5.3 million; the trailing twelve-month figure through Jun 2020 stood at $5.3 million (up 187.69% YoY), and the FY2019 full-year result was $1.1 million, changed N/A from the prior year.
- Convertible Debt rose to $5.3 million in Q2 2020 per GRDX's latest filing, from $3.0 million in the prior quarter.
- Across five years, Convertible Debt topped out at $9.3 million in Q3 2016 and bottomed at $235487.0 in Q1 2018.
- Historically, Convertible Debt has averaged $2.2 million across 5 years, with a median of $1.4 million in 2019.
- The sharpest annual moves came in 2017 and 2019: Convertible Debt sank 95.92% in 2017, then surged 633.99% in 2019.
- Over 5 years, Convertible Debt stood at $9.3 million in 2016, then plunged by 96.21% to $352713.0 in 2017, then dropped by 20.33% to $281024.0 in 2018, then jumped by 283.22% to $1.1 million in 2019, then surged by 390.77% to $5.3 million in 2020.
- According to Business Quant data, Convertible Debt over the past three periods registered $5.3 million, $3.0 million, and $1.1 million for Q2 2020, Q1 2020, and Q4 2019 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | GridAI Technologies | 19.07 Mn | 19.07 Mn | -36,514.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2020 | 5.29 Mn |
| Mar 31, 2020 | 2.99 Mn |
| Dec 31, 2019 | 1.08 Mn |
| Sep 30, 2019 | 1.95 Mn |
| Jun 30, 2019 | 1.84 Mn |
| Mar 31, 2019 | 1.73 Mn |
| Jun 30, 2018 | 281,024.00 |
| Mar 31, 2018 | 235,487.00 |
| Dec 31, 2017 | 352,713.00 |
| Sep 30, 2017 | 379,432.00 |
| Jun 30, 2017 | 645,119.00 |
| Sep 30, 2016 | 9.30 Mn |
| Dec 31, 2015 | 6.15 Mn |